AdvaMedDx. “The Value of Molecular Diagnostics: Advancing Cancer Treatment and Care.” http://dx.advamed.org/sites/dx.advamed.org/files/resource/valuemoleculardiagnostics1.pdf
AdvaMedDx. “An Overview of Diagnostic Test Technologies.” http://dx.advamed.org/sites/dx.advamed.org/files/resource/overviewofdiagnostictestingtechnologies.pdf
AdvaMed analysis of Evaluate Ltd. market research database and member company survey of R&D spending in 2015.
AdvaMedDx. “The Value of Diagnostic Tests in Detecting Cervical Cancer.” http://dx.advamed.org/sites/dx.advamed.org/files/resource/The_Value_of_Diagnostic_Tests_in_Detecting_Cervical_Cancer.pdf
Breast Cancer Facts & Figures 2015-2016. American Cancer Society http://www.cancer.org/acs/groups/content/@research/documents/document/acspc-046381.pdf
American Association for Cancer Research. “AACR Cancer Progress Report 2016.” http://cancerprogressreport.org/2016/Documents/CPR2016.pdf
National Cancer Institute. “BRCA1 and BRCA2: Cancer Risk and Genetic Testing.”https://www.cancer.gov/about-cancer/causes-prevention/genetics/brca-fact...
US National Library of Medicine National Institutes of Health. “Imaging Surveillance of Patients with Breast Cancer after Primary Treatment: Current Recommendations.” https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4347260/
Wallach MD, Jacques. Interpretation of Diagnostic Tests: Eighth Edition. Philadelphia: Lippincott Williams & Wilkins, 2007. Print.
Pinar Karaca-Mandic, PhD1 ; Alan T. Hirsch, MD2 ; Stanley G. Rockson, MD3 ; Sheila H. Ridner, PhD, RN4. The Cutaneous, Net Clinical, and Health Economic Benefits of Advanced Pneumatic Compression
Devices in Patients with Lymphedema. Journal of American Medical Association – Dermatology. October 2015.
Daut RL, Cleeland CS. The prevalence and severity of pain in cancer. Cancer 1982; 50:1913–1918.